Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia

NCT00002701 ·Status: UNKNOWN ·Phase: PHASE3

Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib

NCT00036738 ·Status: COMPLETED ·Phase: PHASE2

Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy

NCT02638467 ·Status: COMPLETED ·Phase: PHASE2

Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia

NCT00003870 ·Status: COMPLETED ·Phase: PHASE2

Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia

NCT00005801 ·Status: COMPLETED ·Phase: PHASE2

Total Marrow and Lymphoid Irradiation and Chemotherapy for High-Risk Acute Leukemia

NCT03408223 ·Status: UNKNOWN ·Phase: NA

A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia

NCT01814488 ·Status: COMPLETED ·Phase: PHASE2

Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer

NCT01375023 ·Status: TERMINATED ·Phase: PHASE2

Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.

NCT06608732 ·Status: RECRUITING ·Phase: PHASE2

Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome

NCT00589316 ·Status: TERMINATED ·Phase: PHASE1

Treatment of Adult ALL With an MRD-directed Programme.

NCT00358072 ·Status: COMPLETED ·Phase: PHASE2

Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission

NCT00186381 ·Status: COMPLETED ·Phase: PHASE2

Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia

NCT03610438 ·Status: UNKNOWN ·Phase: PHASE2

Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

NCT00988715 ·Status: COMPLETED ·Phase: PHASE1

Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention

NCT06626893 ·Status: RECRUITING ·Phase: NA

Mitoxantrone Hydrochloride Liposome Combined With BU/Cy Were Used as a Conditioning Regimen for Patients With Intermediate/Adverse Risk or Persistently Positive MRD AML

NCT06758726 ·Status: NOT_YET_RECRUITING ·Phase: NA

Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

NCT00742625 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01529827 ·Status: COMPLETED ·Phase: PHASE2

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

NCT07046078 ·Status: RECRUITING ·Phase: PHASE2

Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

NCT02122081 ·Status: COMPLETED ·Phase: PHASE1

Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant

NCT01252667 ·Status: COMPLETED ·Phase: PHASE2

Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide

NCT00125606 ·Status: TERMINATED ·Phase: PHASE3

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL

NCT06557161 ·Status: RECRUITING ·Phase: PHASE2

the Efficacy and Safety of Total Myeloid Irradiation (TMI) in the Treatment of Adult Acute Lymphoblastic Leukemia

NCT06461091 ·Status: NOT_YET_RECRUITING

BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive Treatment

NCT00632749 ·Status: COMPLETED ·Phase: PHASE2